Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

SELL
$229.03 - $291.01 $5,496 - $6,984
-24 Reduced 1.19%
2,000 $0
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $454,307 - $512,375
2,024 New
2,024 $456,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.